Valeant Pharmaceuticals Denies Fraud Allegations

Karen Olney, head of thematic equity strategy at UBS, and Bloomberg Intelligence's Sam Fazeli discuss the fraud allegations against Valeant Pharmaceuticals for recording fake sales to phony customers and the outlook for the industry. They speak to Bloomberg's Anna Edwards and Guy Johnson on "Countdown." (Source: Bloomberg)

Infosys CEO Resigns After Criticism From Founders
11:59 - Infosys Ltd. Chief Executive Officer Vishal Sikka has stepped down following criticism from the company’s founder. Chief Operating Officer Pravin Rao will become interim CEO. Bloomberg's Caroline Hyde reports on "Bloomberg Technology." (Source: Bloomberg)
  • Essential's 360 Degree Approach to Smartphones
  • Why Industrial Metals May Be in a Bull Market
  • Who Moved the Most on Bloomberg's Billionaire Index 8/18